Phosducin influences sympathetic activity and prevents stress-induced hypertension in humans and mice

Journal of Clinical Investigation

Volumn 119, Issue 12, 2009, Pages 3597-3612

  Beetz, Nadine ^a   Harrison, Michael D ^b   Brede, Marc ^c   Zong, Xiangang ^d   Urbanski, Michal J ^a   Sietmann, Anika ^e   Kaufling, Jennifer ^f   Barrot, Michel ^f   Seeliger, Mathias W ^g   Vieira Coelho, Maria Augusta ^h   Hamet, Pavel ^i,j   Gaudet, Daniel ^i,k   Seda, Ondrej ^j   Tremblay, Johanne ^i,j   Kotchen, Theodore A ^b   Kaldunski, Mary ^b   Nüsing, Rolf ^l   Szabo, Bela ^a   Jacob, Howard J ^b   Cowley Jr , Allen W ^b   Biel, Martin ^d   Stoll, Monika ^e   Lohse, Martin J ^c   Broeckel, Ulrich ^b   Hein, Lutz ^a   more..

^a UNIVERSITY OF FREIBURG   (Germany)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f CNRS   (France)

^g UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^h UNIVERSITY OF PORTO   (Portugal)

ⁱ UNIVERSITÉ DE MONTRÉAL   (Canada)

^j CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^k CHICOUTIMI HOSPITAL   (Canada)

^l GOETHE UNIVERSITY   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CATECHOLAMINE; DOBUTAMINE; NORADRENALIN; PHOSDUCIN;

ADRENERGIC SYSTEM; ADULT; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL FUNCTION; BLOOD VESSEL REACTIVITY; CATECHOLAMINE METABOLISM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; GENE DELETION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HEART FUNCTION; HOMOZYGOSITY; HUMAN; HYPERTENSION; HYPERTROPHY; MEMBRANE DEPOLARIZATION; MOUSE; MUSCLE CELL; NERVE CONDUCTION; NERVE POTENTIAL; NERVE STIMULATION; NONHUMAN; PHENOTYPE; POSTGANGLIONIC NERVE; PRIORITY JOURNAL; PUPIL; SINGLE NUCLEOTIDE POLYMORPHISM; STANDING; STRESS; SURGICAL STRESS; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; VASODILATATION; WALKING;

ADULT; AGED; ALLELES; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOOD PRESSURE; DNA; EPINEPHRINE; EYE PROTEINS; FEMALE; GTP-BINDING PROTEIN REGULATORS; HOMOZYGOTE; HUMANS; HYPERTENSION; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MIDDLE AGED; MODELS, CARDIOVASCULAR; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEUROSECRETORY SYSTEMS; PHENOTYPE; PHOSPHOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; STRESS, PHYSIOLOGICAL; SYMPATHETIC NERVOUS SYSTEM;

EID: 72849116579     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI38433     Document Type: Article

References (47)

1. Kearney, P.M., et al. 2005. Global burden of hypertension: analysis of worldwide data. Lancet. 365:217-223. (Pubitemid 40138015)
2. Janeway, T.C. 1907. The clinical study of blood pressure. D. Appleton & Co. New York, New York, USA. 300 pp.
3. Cowley, A.W., Jr. 2006. The genetic dissection of essential hypertension. Nat. Rev. Genet. 7:829-840.
4. Esler, M. 2000. The sympathetic system and hypertension. Am. J. Hypertens. 13:99S-105S.
5. Guyenet, P.G. 2006. The sympathetic control of blood pressure. Nat. Rev. Neurosci. 7:335-346.
6. Rockman, H.A., Koch, W.J., and Lefkowitz, R.J. 2002. Seven-transmembrane- spanning receptors and heart function. Nature. 415:206-212.
7. Wirth, A., et al. 2008. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat. Med. 14:64-68.
8. Tang, K.M., et al. 2003. Regulator of G-protein signaling- 2 mediates vascular smooth muscle relaxation and blood pressure. Nat. Med. 9:1506-1512.
9. Bauer, P.H., et al. 1992. Phosducin is a protein kinase A-regulated G-protein regulator. Nature. 358:73-76.
10. Gaudet, R., Bohm, A., and Sigler, P.B. 1996. Crystal structure at 2.4 angstroms resolution of the complex of transducin betagamma and its regulator, phosducin. Cell. 87:577-588. (Pubitemid 26374330)
11. Humrich, J., et al. 2005. Phosducin-like protein regulates G-protein betagamma folding by interaction with tailless complex polypeptide-1alpha: dephosphorylation or splicing of PhLP turns the switch toward regulation of G beta gamma folding. J. Biol. Chem. 280:20042-20050.
12. Knol, J.C., Engel, R., Blaauw, M., Visser, A.J., and van Haastert, P.J. 2005. The phosducin-like protein PhLP1 is essential for G beta gamma dimer formation in Dictyostelium discoideum. Mol. Cell. Biol. 25:8393-8400. (Pubitemid 41263027)
13. Lukov, G.L., Hu, T., McLaughlin, J.N., Hamm, H.E., and Willardson, B.M. 2005. Phosducin-like protein acts as a molecular chaperone for G protein beta gamma dimer assembly. EMBO J. 24:1965-1975. (Pubitemid 40896168)
14. Zhu, X., and Craft, C.M. 1998. Interaction of phosducin and phosducin isoforms with a 26S proteasomal subunit, SUG1. Mol. Vis. 4:13.
15. Roseboom, P.H., et al. 1998. Natural melatonin 'knockdown' in C57BL/6J mice: rare mechanism truncates serotonin N-acetyltransferase. Brain Res. Mol. Brain Res. 63:189-197.
16. Kaufling, J., Veinante, P., Pawlowski, S.A., Freund- Mercier, M.J., and Barrot, M. 2009. Afferents to the GABAergic tail of the ventral tegmental area in the rat. J. Comp. Neurol. 513:597-621.
17. Minson, J.B., Arnolda, L.F., and Llewellyn-Smith, I.J. 2002. Neurochemistry of nerve fibers apposing sympathetic preganglionic neurons activated by sustained hypotension. J. Comp. Neurol. 449:307-318.
18. Abecasis, G.R., Cardon, L.R., and Cookson, W.O. 2000. A general test of association for quantitative traits in nuclear families. Am. J. Hum. Genet. 66:279-292.
19. Barrett, J.C., Fry, B., Maller, J., and Daly, M.J. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 21:263-265. (Pubitemid 40202029)
20. Benjamini, Y., and Hochberg, Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Series B Stat. Methodol. 57:289-300.
21. Saxena, R., et al. 2007. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 316:1331-1336.
22. Wellcome Trust Case Control Consortium. 2007. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 447:661-678.
23. Sokolov, M., et al. 2004. Phosducin facilitates light-driven transducin translocation in rod photoreceptors. Evidence from the phosducin knockout mouse. J. Biol. Chem. 279:19149-19156. (Pubitemid 38623346)
24. Craft, C.M., Lolley, R.N., Seldin, M.F., and Lee, R.H. 1991. Rat pineal gland phosducin: cDNA isolation, nucleotide sequence, and chromosomal assignment in the mouse. Genomics. 10:400-409.
25. Goto, M., Oshima, I., Tomita, T., and Ebihara, S. 1989. Melatonin content of the pineal gland in different mouse strains. J. Pineal Res. 7:195-204. (Pubitemid 19192739)
26. Ritz, E. 2007. Total cardiovascular risk management. Am. J. Cardiol. 100:53J-60J.
27. Lewington, S., Clarke, R., Qizilbash, N., Peto, R., and Collins, R. 2002. Age-specific relevance of usual blood pressure to vascular mortality: a metaanalysis of individual data for one million adults in 61 prospective studies. Lancet. 360:1903-1913. (Pubitemid 35472129)
28. Antman, E.M., et al. 2007. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 115:1634-1642.
29. Aw, T.J., Haas, S.J., Liew, D., and Krum, H. 2005. Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure. Arch. Intern. Med. 165:490-496. (Pubitemid 40344379)
30. Dinchuk, J.E., et al. 1995. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature. 378:406-409.
31. Morham, S.G., et al. 1995. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell. 83:473-482.
32. Yang, T., et al. 2005. Influence of genetic background and gender on hypertension and renal failure in COX-2-deficient mice. Am. J. Physiol. Renal Physiol. 288:F1125-F1132.
33. Kohara, K., et al. 2008. Identification of hypertension- susceptibility genes and pathways by a systemic multiple candidate gene approach: the millennium genome project for hypertension. Hypertens. Res. 31:203-212.
34. Victor, R.G., and Shafiq, M.M. 2008. Sympathetic neural mechanisms in human hypertension. Curr. Hypertens. Rep. 10:241-247.
35. Hein, L., Barsh, G.S., Pratt, R.E., Dzau, V.J., and Kobilka, B.K. 1995. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature. 377:744-747.
36. Klenk, C., Humrich, J., Quitterer, U., and Lohse, M.J. 2006. SUMO-1 controls the protein stability and the biological function of phosducin. J. Biol. Chem. 281:8357-8364. (Pubitemid 43847936)
37. Davis, B.J., et al. 1999. Anovulation in cyclooxygenase- 2-deficient mice is restored by prostaglandin E2 and interleukin-1beta. Endocrinology. 140:2685-2695.
38. Gilsbach, R., Kouta, M., Bonisch, H., and Bruss, M. 2006. Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data. Biotechniques. 40:173-177. (Pubitemid 46542637)
39. Stolle, K., et al. 2005. Cloning, cellular localization, genomic organization, and tissue-specific expression of the TGFbeta1-inducible SMAP-5 gene. Gene. 351:119-130. (Pubitemid 40732624)
40. Gilsbach, R., et al. 2007. Heterozygous alpha(2C)- adrenoceptor-deficient mice develop heart failure after transverse aortic constriction. Cardiovasc. Res. 75:728-737.
41. Brede, M., et al. 2001. Vascular hypertrophy and increased P70S6 kinase in mice lacking the angiotensin II AT(2) receptor. Circulation. 104:2602-2607.
42. Brede, M., et al. 2003. Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes. Mol. Endocrinol. 17:1640-1646. (Pubitemid 36930476)
43. Hein, L., Altman, J.D., and Kobilka, B.K. 1999. Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature. 402:181-184.
44. Hamet, P., et al. 2005. Quantitative founder-effect analysis of French Canadian families identifies specific loci contributing to metabolic phenotypes of hypertension. Am. J. Hum. Genet. 76:815-832.
45. Kotchen, T.A., et al. 2002. Identification of hypertension- related QTLs in African American sib pairs. Hypertension. 40:634-639.
46. Gabriel, S.B., et al. 2002. The structure of haplotype blocks in the human genome. Science. 296:2225-2229.
47. Kruglyak, L., Daly, M.J., Reeve-Daly, M.P., and Lander, E.S. 1996. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am. J. Hum. Genet. 58:1347-1363. (Pubitemid 26153846)